InvestorsHub Logo
Followers 29
Posts 3997
Boards Moderated 0
Alias Born 10/16/2003

Re: noretreat post# 214

Saturday, 01/23/2016 10:37:48 PM

Saturday, January 23, 2016 10:37:48 PM

Post# of 1085
What I like about Leong....

Checked back, and its good to see that he was touting ESPR's potential back in 2014, before it went from $15 to $120.....obviously things didn't work out there, but it speaks to the potential for this type of therapy to catch fire.

And if RVX's ph III trial does achieve its end point....the sky could be the limit here.

If you want to taste the fruit, you have to go out on a limb. But if you wait for the herd to move out on the limb....the branch tends to snap.